Dr. Kasey Leger, MD

NPI: 1548316169
Total Payments
$22,514
2024 Payments
$1,509
Companies
2
Transactions
21

Payment Breakdown by Category

Consulting$14,066 (62.5%)
Other$4,990 (22.2%)
Travel$2,467 (11.0%)
Food & Beverage$990.50 (4.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $14,066 7 62.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,990 2 22.2%
Travel and Lodging $2,467 4 11.0%
Food and Beverage $990.50 8 4.4%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $16,529 15 $0 (2024)
BTG International, Inc. $5,985 6 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,509 2 JAZZ PHARMACEUTICALS INC. ($1,509)
2023 $5,926 4 JAZZ PHARMACEUTICALS INC. ($5,926)
2022 $1,680 1 JAZZ PHARMACEUTICALS INC. ($1,680)
2021 $4,160 3 JAZZ PHARMACEUTICALS INC. ($4,160)
2019 $5,985 6 BTG International, Inc. ($5,985)
2017 $3,254 5 Jazz Pharmaceuticals Inc. ($3,254)

All Payment Transactions

21 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/16/2024 JAZZ PHARMACEUTICALS INC. Consulting Fee Cash or cash equivalent $1,386.00 General
12/07/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug), VYXEOS, Defitelio Food and Beverage In-kind items and services $123.12 General
Category: HEMATOLOGY/ONCOLOGY
12/18/2023 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,840.00 General
Category: HEMATOLOGY/ONCOLOGY
12/09/2023 JAZZ PHARMACEUTICALS INC. Food and Beverage In-kind items and services $146.32 General
12/08/2023 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Food and Beverage In-kind items and services $99.55 General
Category: HEMATOLOGY/ONCOLOGY
08/01/2023 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $3,840.00 General
Category: HEMATOLOGY/ONCOLOGY
12/19/2022 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $1,680.00 General
Category: HEMATOLOGY/ONCOLOGY
06/22/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: HEMATOLOGY/ONCOLOGY
06/22/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $1,000.00 General
Category: HEMATOLOGY/ONCOLOGY
01/18/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $1,160.00 General
Category: HEMATOLOGY/ONCOLOGY
07/11/2019 BTG International, Inc. VORAXAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,150.00 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
07/11/2019 BTG International, Inc. VORAXAZE (Drug) Travel and Lodging Cash or cash equivalent $1,579.00 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
07/11/2019 BTG International, Inc. VORAXAZE (Drug) Food and Beverage Cash or cash equivalent $123.25 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
06/14/2019 BTG International, Inc. VORAXAZE (Drug) Travel and Lodging In-kind items and services $620.59 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
06/14/2019 BTG International, Inc. VORAXAZE (Drug) Travel and Lodging In-kind items and services $171.35 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
06/13/2019 BTG International, Inc. VORAXAZE (Drug) Food and Beverage In-kind items and services $340.47 General
Category: TOXICITY ANTIDOTE METHOTREXATE TOXICITY
12/17/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Travel and Lodging In-kind items and services $96.53 General
Category: Oncology
12/08/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $72.79 General
Category: Oncology
12/08/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Oncology
12/08/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $35.00 General
Category: Oncology
12/04/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Oncology

About Dr. Kasey Leger, MD

Dr. Kasey Leger, MD is a Pediatrics healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548316169.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kasey Leger, MD has received a total of $22,514 in payments from pharmaceutical and medical device companies, with $1,509 received in 2024. These payments were reported across 21 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($14,066).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Hematology-Oncology, Pediatric Hematology-Oncology
  • Location Seattle, WA
  • Active Since 01/26/2007
  • Last Updated 09/04/2014
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1548316169

Products in Payments

  • RYLAZE (Drug) $11,743
  • VORAXAZE (Drug) $5,985
  • Erwinaze (Drug) $3,254

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Seattle